Exhale

The official blog of the Lung Institute.

Is Black Lung Treatable? 

Lung Graphic

There is no cure for black lung disease, so treatment usually focuses on relieving symptoms and improving quality of life. Black lung, or coal worker’s pneumoconiosis (CWP), is an occupational lung disease that most commonly affects miners who have inhaled coal dust over an extended period of time.

A black lung treatment regimen will vary based on whether a person has a simple or complicated form of CWP and what specific symptoms are being experienced. Generally speaking, medications and supplemental oxygen may be used to improve breathing and control co-existing symptoms from related conditions, such as chronic obstructive pulmonary disease (COPD). Lung transplantation may be recommended for patients with very severe cases of black lung.

Autologous cellular therapy is an alternative black lung treatment that is showing encouraging results in some patients. This treatment involves using the patient’s own cells to promote the body’s natural healing processes, which may in turn help reduce lung inflammation and ease unpleasant symptoms like coughing and shortness of breath. Because cells are found naturally in the body and are not a drug, most patients don’t experience any negative side effects.

The Lung Institute offers the latest breakthroughs in autologous cellular therapy to adults with black lung disease and other chronic lung conditions. As the only cellular therapy center in the world to focus exclusively on lung disease, the Lung Institute can be your first choice for  cellular-based black lung treatment. Consider contacting our friendly medical team today at (800) 729-3065 if traditional treatment approaches are not providing the symptom relief you desire. We will be happy to answer any questions you may have and determine if you are a potential candidate for cellular therapy.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.